We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+5.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$8.36B
AUM Growth
+$811M
Cap. Flow
+$513M
Cap. Flow %
6.13%
Top 10 Hldgs %
9.6%
Holding
2,400
New
687
Increased
686
Reduced
568
Closed
456

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.52%
2 Technology 13.89%
3 Financials 12.78%
4 Industrials 11.24%
5 Healthcare 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVEO icon
1876
Civeo
CVEO
$379M
$112K ﹤0.01%
+2,256
New +$106K
VOXX
1877
DELISTED
VOXX International Corporation Class A
VOXX
$109K ﹤0.01%
+20,882
New +$112K
MLNT
1878
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$106K ﹤0.01%
5,342
+2,774
+108% +$70.1K
TIS
1879
DELISTED
Orchids Paper Products, Inc.
TIS
$106K ﹤0.01%
+32,200
New +$113K
ARCO icon
1880
Arcos Dorados Holdings
ARCO
$1.73B
$105K ﹤0.01%
17,277
-41,921
-71% -$277K
MGI
1881
DELISTED
MoneyGram International, Inc. New
MGI
$104K ﹤0.01%
19,400
+1,685
+10% +$10.6K
CMO
1882
DELISTED
Capstead Mortgage Corp.
CMO
$104K ﹤0.01%
+13,107
New +$110K
PLUG icon
1883
Plug Power
PLUG
$2.92B
$102K ﹤0.01%
+53,173
New +$104K
CYTK icon
1884
Cytokinetics
CYTK
$11B
$100K ﹤0.01%
+10,162
New +$81.5K
PRTK
1885
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$100K ﹤0.01%
+10,347
New +$104K
SNDX icon
1886
Syndax Pharmaceuticals
SNDX
$1.84B
$99K ﹤0.01%
+12,298
New +$87.7K
BRG
1887
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$99K ﹤0.01%
10,100
-2,797
-22% -$26.6K
SGYP
1888
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$99K ﹤0.01%
58,464
+17,413
+42% +$31.2K
MBT
1889
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$98K ﹤0.01%
11,491
-150,576
-93% -$1.24M
FTD
1890
DELISTED
FTD Companies, Inc. Common Stock
FTD
$97K ﹤0.01%
36,750
+22,131
+151% +$81.1K
INO icon
1891
Inovio Pharmaceuticals
INO
$79.8M
$93K ﹤0.01%
1,390
-10,701
-89% -$596K
MFA
1892
MFA Financial
MFA
$929M
$88K ﹤0.01%
2,993
-20,455
-87% -$631K
QMCO icon
1893
Quantum Corp
QMCO
$437M
$87K ﹤0.01%
1,804
+1,182
+190% +$48.3K
AKTS
1894
DELISTED
Akoustis Technologies Inc
AKTS
$87K ﹤0.01%
+11,000
New +$88.9K
TALO.WS
1895
DELISTED
Talos Energy, Inc. Warrants to purchase common stock (expiring February 28, 2021)
TALO.WS
$87K ﹤0.01%
19,146
RSYS
1896
DELISTED
Radisys Corp
RSYS
$87K ﹤0.01%
+53,558
New +$83K
LYTS icon
1897
LSI Industries
LYTS
$853M
$86K ﹤0.01%
18,797
-7,965
-30% -$40K
HPR
1898
DELISTED
HighPoint Resources Corporation
HPR
$85K ﹤0.01%
+349
New +$99.6K
SOHO
1899
DELISTED
Sotherly Hotels
SOHO
$84K ﹤0.01%
11,600
+500
+5% +$3.57K
SHLD
1900
DELISTED
Sears Holding Corporation
SHLD
$81K ﹤0.01%
83,400
+58,798
+239% +$98.1K

Similar funds

Squarepoint's Q3 2018 Portfolio in Review

As of Q3 2018, Squarepoint held 2,400 positions worth $8.36B, up 11% from $7.55B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Squarepoint deployed $513M of net new capital in Q3 2018, opening 687 new positions and adding to 686 existing holdings. Its largest new stake was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Cigna, an estimated $69.1M trimmed.

  • Squarepoint's largest Q3 2018 buy was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.
  • Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q3 2018, an estimated $58.8M increase.
  • Squarepoint's biggest Q3 2018 reduction was Cigna, cutting an estimated $69.1M.
  • Squarepoint fully exited Vanguard FTSE Emerging Markets ETF in Q3 2018, selling an estimated $79.7M.
  • Squarepoint's ten largest holdings make up 9.6% of its $8.36B portfolio in Q3 2018.
  • Squarepoint opened 687 new positions and closed 456 in Q3 2018.
  • Squarepoint's portfolio value rose 11% quarter-over-quarter to $8.36B.

Based on Squarepoint's 13F filing for Q3 2018, filed 14 Nov 2018.